Skip to main content
. 2020 Mar 6;19(5):3177–3188. doi: 10.3892/etm.2020.8576

Figure 9.

Figure 9

Fisetin significantly reduces platelet aggregation rate in human blood samples. (A) Rate of platelet aggregation in fisetin (1x10-9-1x10-5 M), dipyridamole (2x10-6 mol/l), clopidogrel (3x10-5 mol/l), and aspirin (2.8x10-4 mol/l) treated groups was significantly reduced. (B) Antiplatelet effect of fisetin and quercetin was dose dependent with half maximal inhibitory concentration of 4.54x10-7 mol/l and 2.71x10-7 mol/l for fisetin and quercetin, respectively. **P<0.01 vs. control.